Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

321.68
-6.4800-1.97%
Volume:562.13K
Turnover:181.91M
Market Cap:42.50B
PE:975.22
High:329.92
Open:325.49
Low:321.37
Close:328.16
52wk High:495.55
52wk Low:205.87
Shares:132.11M
Float Shares:126.15M
Volume Ratio:0.42
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3299
EPS(LYR):-2.1790
ROE:32.73%
ROA:3.65%
PB:181.70
PE(LYR):-147.62

Loading ...

Earning Preview: Alnylam Pharmaceuticals revenue is expected to increase by 1.01 billion, and institutional views are predominantly bullish

Earnings Agent
·
Feb 05

Has The Recent Pullback In Alnylam Pharmaceuticals (ALNY) Opened A Valuation Opportunity?

Simply Wall St.
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Amgen (AMGN) and Indivior (INDV)

TIPRANKS
·
Jan 31

Alnylam price target lowered to $462 from $529 at BofA

TIPRANKS
·
Jan 30

Alnylam Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 30

U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises

Reuters
·
Jan 30

Press Release: Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Jan 29

Alnylam Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2026-01-23

Reuters
·
Jan 24

Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Jan 20

RBC Cuts Price Target on Alnylam Pharmaceuticals to $465 From $500, Keeps Outperform Rating

MT Newswires Live
·
Jan 20

Alnylam Pharmaceuticals on Track for Lowest Close Since July -- Data Talk

Dow Jones
·
Jan 17

Alnylam EVP and Chief Commercial Officer Tolga Tanguler Reports Disposal of Common Shares

Reuters
·
Jan 15

Alnylam CSO Kevin Fitzgerald Reports Disposal of Common Shares

Reuters
·
Jan 15

Bernstein Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
Jan 14

Evercore ISI Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Jan 13

Analysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Foghorn Therapeutics (FHTX)

TIPRANKS
·
Jan 13

Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale

Benzinga_recent_news
·
Jan 13

Alnylam 2026 guidance reflects continued momentum, says H.C. Wainwright

TIPRANKS
·
Jan 13

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2026-01-12

Reuters
·
Jan 13